|
| | Primary complaint | Secondary complaint | Nondizzy |
| (n = 232, 2.3%) | (n = 984, 9.8%) | (n = 8860, 87.9%) |
|
| Nonspecific dizziness (R42) | 47 (20.3%) | 58 (5.9%) | 15 (0.2%) |
| Dysfunction of the peripheral vestibular system (H81) | 37 (15.9%) | 9 (0.9%) | 4 (0.0%) |
| Somatization disorders, depression, and anxiety (F00–F03, F13–F48, and R53, R54) | 20 (8.6%) | 32 (3.3%) | 280 (3.2%) |
| Trauma related (S00–S02, S06–S14, and T79) | 19 (8.2%) | 138 (14.0%) | 2135 (24.1%) |
| Syncope and collapse (R55) | 14 (6.0%) | 47 (4.8%) | 106 (1.2%) |
| Cerebral hemorrhage or ischemic disease | 12 (5.2%) | 39 (4.0%) | 268 (3.0%) |
| Cerebral hemorrhage (I61) | 1 (0.4%) | 1 (0.1%) | 10 (0.1%) |
| Acute ischemic disease (I63 and I64) | 3 (1.3%) | 25 (2.5%) | 78 (0.9%) |
| Cerebrovascular disease (I67) | 1 (0.4%) | 3 (0.3%) | 149 (1.7%) |
| Sequelae of cerebrovascular disease (I69) | 3 (1.3%) | 0 | 0 |
| TIA (G45 w/out G45.4) | 3 (1.3%) | 10 (1.0%) | 31 (3.5%) |
| TGA (G45.4) | 1 (0.4%) | 0 | 0 |
| Orthostasis (I95 and I98) | 11 (4.7%) | 5 (0.5%) | 4 (0.0%) |
| Drug related problems, intoxications, and poisoning (F10–F13, T36–T47, T50-T51, T65, and T78) | 10 (4.3%) | 18 (1.8%) | 207 (2.3%) |
| Arrhythmia (R00 and I44–I49) | 9 (3.9%) | 44 (4.5%) | 114 (1.3%) |
| Hypertension (I10) | 9 (3.9%) | 22 (2.2%) | 71 (0.8%) |
| Other | 7 (3.0%) | 118 (12.0%) | 1750 (19.8%) |
| Acute infections of the upper airway (J00–J11) | 3 (1.3%) | 59 (6.0%) | 220 (2.5%) |
| Abdominal and pelvic pain (R10) | — | 33 (3.4%) | 539 (6.1%) |
| Throat and chest pain (R07) | — | 62 (6.3%) | 424 (4.8%) |
| Back pain (M54) | — | 16 (1.6%) | 345 (3.9%) |
| Breathing disorders (R06) | — | 17 (1.7%) | 227 (2.6%) |
| Disease of the skin (L00–L08) | — | 4 (0.4%) | 155 (1.7%) |
| Headache (G44 and R51) | — | 33 (3.4%) | 112 (1.3%) |
|
